SCHEMBL24909758

SCHEMBL24909758

O=S(=O)(c1ccc(F)cc1)c1nccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 2/20 0.46
CYP2A6 P11509 1/20 0.43
CHEK1 O14757 1/20 0.43
CDK8 P49336 1/20 0.43
NEK2 P51955 1/20 0.43
LIMK1 P53667 1/20 0.43
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
PIK3CA P42336 1/20 0.41
NFE2L2 Q16236 2/20 0.41
KEAP1 Q14145 1/20 0.41
TRPA1 O75762 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5422878 0.87 CYP2A6 (0.48) CYP2A6LMNATSHRPIK3CAMEN1
SCHEMBL29277538 0.84 HTR1A (0.52) CYP2A6LMNAHTTMEN1KMT2A
SCHEMBL29277541 0.84 KMT2A (0.55) COMTCYP2A6HSD17B10LMNATSHR
SCHEMBL29277545 0.84 HTT (0.47) CYP2A6HSD17B10LMNAHTTPIK3CA
SCHEMBL29277533 0.83 CYP2A6 (0.55) CYP2A6HSD17B10LMNATSHRKMT2A
SCHEMBL8353263 0.80 PTGS2 (0.41) COMTCYP2A6HSD17B10LMNAMEN1
SCHEMBL14488472 0.77 PIK3CA (0.43) COMTCHEK1CDK8NEK2LIMK1
SCHEMBL29277551 0.75 NFE2L2 (0.47) NFE2L2MEN1KMT2AHTR6HTR2A
SCHEMBL29277548 0.75 CYP2A6 (0.47) CYP2A6MEN1KMT2AALDH1A1RAB9A
SCHEMBL329993 0.74 CYP2A6 (0.53) CYP2A6HSD17B10LMNATSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117304106-A Isoquinoline sulfone compound and preparation method and application thereof 江西师范大学 2023-12-29 CN disclosed
US-20230025531-A1 Novel Isoquinoline Derivative, Preparing Method Thereof, and Pharmaceutical Composition for Preventing or Treating Autophagy Related Diseases Containing the Same as an Active Ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025531-A1 Novel Isoquinoline Derivative, Preparing Method Thereof, and Pharmaceutical Composition for Preventing or Treating Autophagy Related Diseases Containing the Same as an Active Ingredient ATG7, TFEB, BECN1 COMT 395/4885CYP2A6 1244/4885CHEK1 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.